title: Senescence-Derived Extracellular Molecules as Modulators of Oral Cancer Development: A Mini-Review.
abstract: Oral cancers are predominantly oral squamous cell carcinomas (OSCCs) derived from keratinocytes, and there is now very detailed knowledge of the genetics and molecular biology of the epithelial tumourigenic component of these cancers, including the identification of cancer stem or tumour-initiating cells. Several key genetic alterations have been identified including the near ubiquitous loss of the CDKN2A/p16INK4A and p53 pathways and telomerase activation, together with frequent inactivation of the NOTCH1 canonical pathway either by somatic genetic alterations or by the presence of human papilloma virus. There is also evidence that OSCCs arise from a 'field' of altered cells and that malignant conversion takes place pre-dominantly at the microscopic level. However, in the last decade, it has been realised that tumour development and progression are influenced by the cells of the microenvironment with cross-talk between the epithelial (tumour) and mesenchymal components. OSCCs, especially those that have bypassed cellular senescence, produce an array of proteins and metabolites that induce cellular senescence in the normal surrounding cells; indeed, senescence is a common property of cancer-associated fibroblasts (CAFs). Cellular senescence is defined as an irreversible cell cycle arrest and is associated with the release of molecules known as the senescence-associated secretory phenotype that can selectively promote the growth of pre-neoplastic keratinocytes (osteopontin) and cancer invasion (transforming growth factor β, matrix metalloproteinases, interleukin 6 and lactate). In addition, both old and new work has shown that keratinocytes harbouring NOTCH loss-of-function mutations that lead to defective keratinocyte differentiation and loss of squamous epithelial barrier function may act as a tumour-promoting stimulus for initiated cells harbouring RAS pathway mutations by activating a wound response in the tumour mesenchyme. Thus, not all keratinocytes in the tumour tissue may be tumourigenic and may instead act as promoters of tumour growth and progression analogous to the much-studied CAFs which co-evolve with the genetically altered tumourigenic cells. This new data is discussed in relation to attempts to develop novel non-invasive diagnostics and therapeutics for oral cancer.
authors.affiliation: Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
authors.forename: Eric Kenneth
authors.initials: EK
authors.lastname: Parkinson
authors.forename: Emma L
authors.initials: EL
authors.lastname: James
authors.forename: Stephen S
authors.initials: SS
authors.lastname: Prime
mesh_terms: D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000209:etiology; D016922:Cellular Senescence / Q000235:genetics / Q000502:physiology*; D005347:Fibroblasts / Q000473:pathology / Q000502:physiology; D042822:Genomic Instability; D006801:Humans; D015603:Keratinocytes / Q000473:pathology / Q000502:physiology; D055442:Metabolome; D008954:Models, Biological; D009062:Mouth Neoplasms / Q000209:etiology*; D027383:Papillomaviridae / Q000472:pathogenicity; D051881:Receptor, Notch1 / Q000235:genetics / Q000502:physiology; D059505:Telomere Homeostasis; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000502:physiology
chemical_list: C497761:NOTCH1 protein, human; D051881:Receptor, Notch1; D025521:Tumor Suppressor Proteins